| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ALUMIS INC. | Director | Common Stock | 23.5K | $376K | $16.00 | Jul 1, 2024 | Direct |
| ArriVent Biopharma, Inc. | President and CEO, Director | Common Stock | 394K | Jan 25, 2024 | Held by The MAKS Yao Trust | ||
| ArriVent Biopharma, Inc. | President and CEO, Director | Common Stock | 219K | Jan 25, 2024 | Held by ArriMed BioPharma, LLC | ||
| NexImmune, Inc. | Director | Stock Option (right to buy) | 45K | Jul 5, 2023 | Direct | ||
| ALUMIS INC. | Director | Stock Option (Right to Buy) | 4.28K | Jul 1, 2024 | Direct | ||
| ALUMIS INC. | Director | Class A Common Stock | 0 | Jul 1, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALMS | ALUMIS INC. | Jun 27, 2024 | 7 | $0 | 4 | Jul 1, 2024 | Director |
| ALMS | ALUMIS INC. | Jun 27, 2024 | 0 | $0 | 3 | Jun 27, 2024 | Director |
| AVBP | ArriVent Biopharma, Inc. | Jan 25, 2024 | 0 | $0 | 3 | Jan 25, 2024 | President and CEO, Director |
| NEXI | NexImmune, Inc. | Jul 5, 2023 | 1 | $0 | 4 | Jul 7, 2023 | Director |
| NEXI | NexImmune, Inc. | Apr 4, 2023 | 6 | $0 | 4 | Apr 6, 2023 | Director |
| NEXI | NexImmune, Inc. | Jun 13, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |